[
  {
    "ts": null,
    "headline": "Insulet: The Growth Doesn't Stop Here",
    "summary": "Insulet: The Growth Doesn't Stop Here",
    "url": "https://finnhub.io/api/news?id=0f3f0d649b1186327e4a555ad2fb6a7144d529a7c53d736941c523a4cb55ac9c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772134080,
      "headline": "Insulet: The Growth Doesn't Stop Here",
      "id": 139241247,
      "image": "",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=0f3f0d649b1186327e4a555ad2fb6a7144d529a7c53d736941c523a4cb55ac9c"
    }
  },
  {
    "ts": null,
    "headline": "ORMP: Enabling Participation in Both ORMP & LFWD Businesses Expected to Enhance Shareholder Value",
    "summary": "By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Transaction enables exposure to both oral drug delivery program & medical device businesses Oramed Pharmaceuticals (NASDAQ:ORMP) recently signed a binding agreement for a transformative strategic transaction with Lifeward Ltd and another accredited investor. Lifeward is a medical device company focused on devices to aid physical",
    "url": "https://finnhub.io/api/news?id=e13891adf89157e7ef98e935598c383224299094fd8bab8d6c98c66766528733",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772122200,
      "headline": "ORMP: Enabling Participation in Both ORMP & LFWD Businesses Expected to Enhance Shareholder Value",
      "id": 139239924,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Transaction enables exposure to both oral drug delivery program & medical device businesses Oramed Pharmaceuticals (NASDAQ:ORMP) recently signed a binding agreement for a transformative strategic transaction with Lifeward Ltd and another accredited investor. Lifeward is a medical device company focused on devices to aid physical",
      "url": "https://finnhub.io/api/news?id=e13891adf89157e7ef98e935598c383224299094fd8bab8d6c98c66766528733"
    }
  },
  {
    "ts": null,
    "headline": "Got $10,000? This Under‑the‑Radar Medical Device Giant Could Be a Millionaire Maker by 2036.",
    "summary": "One of the biggest growth stories in medical devices is Intuitive Surgical, but don't overlook the opportunity ahead for this competitor.",
    "url": "https://finnhub.io/api/news?id=1796c0c82b14c9a3ac2c7e8c7fb738e2e2aa5f8e454051d583fdd5bf7d9701bf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772115900,
      "headline": "Got $10,000? This Under‑the‑Radar Medical Device Giant Could Be a Millionaire Maker by 2036.",
      "id": 139235456,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "One of the biggest growth stories in medical devices is Intuitive Surgical, but don't overlook the opportunity ahead for this competitor.",
      "url": "https://finnhub.io/api/news?id=1796c0c82b14c9a3ac2c7e8c7fb738e2e2aa5f8e454051d583fdd5bf7d9701bf"
    }
  },
  {
    "ts": null,
    "headline": "Is Medtronic Stock Underperforming the S&P 500?",
    "summary": "Medtronic has underperformed the S&P 500 over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.",
    "url": "https://finnhub.io/api/news?id=ed3220a0c6582bcb1c5bdf6e659e5d833ca2a6b327893db673b0aa8779c63003",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772111673,
      "headline": "Is Medtronic Stock Underperforming the S&P 500?",
      "id": 139237189,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic has underperformed the S&P 500 over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.",
      "url": "https://finnhub.io/api/news?id=ed3220a0c6582bcb1c5bdf6e659e5d833ca2a6b327893db673b0aa8779c63003"
    }
  }
]